FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: ONSHORING MANUFACTURING OF DRUGS AND BIOLOGICAL PRODUCTS; PUBLIC MEETING; REQUEST FOR COMMENTS

WASHINGTON, Aug. 8 -- Food and Drug Administration has issued a notice called: Onshoring Manufacturing of Drugs and Biological Products; Public Meeting; Request for Comments.

The notice was published in the Federal Register on Aug. 8 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA, the Agency, or we) is announcing the establishment of a docket to solicit public comments on issues related to accelerating the establishment of new pharmaceutical manufacturing facilities in the United States. FDA is also announcing the following public meeting entitled "Onshoring Manufacturing of Drugs and Biological Products." At this meeting, FDA will present a draft ...